ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Information for professionals for Mg5-Granoral®:OM Pharma Suisse SA
Complete information for professionalsDDDÄnderungen anzeigenPrint 
Composition.Galenic FormIndication.UsageContra IndicationWarning restrictions.Interactions.Pregnancy
Driving abilityUnwanted effectsOverdoseEffectsPharm.kinetikPreclinicalOther adviceSwissmedic-Nr.
PackagesRegistration ownerLast update of information 
A12CC05 - Magnesium AspartateATC-DDD Version 2016. Source: WHO
A - Alimentary Tract and Metabolism
 
A12 - Mineral Supplements

This group contains mineral supplements used for treatment of mineral deficiency. All parenteral solutions of electrolytes are classified in B05B or in B05X. Magnesium carbonate used for treatment of mineral deficiency is classified in A02AA01.

A12C - Other Mineral Supplements

This group comprises other minerals.
See also B05 - Blood substitutes and perfusion solutions.

A12CC - Magnesium

Combinations with subtherapeutic amounts of vitamins are included in this group.

The DDDs for the various magnesium salts are equivalent to an assumed daily requirement of 300 mg magnesium (oral dose). -

A12CC05 - Magnesium Aspartate
2024 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home